Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

Role of heregulin in human cancer.

Breuleux M.

Cell Mol Life Sci. 2007 Sep;64(18):2358-77. Review.

PMID:
17530167
2.
3.
4.

Expression of heregulin by mouse mammary tumor cells: role in activation of ErbB receptors.

Schmitt M, Walker MP, Richards RG, Bocchinfuso WP, Fukuda T, Medina D, Kittrell FS, Korach KS, DiAugustine RP.

Mol Carcinog. 2006 Jul;45(7):490-505.

PMID:
16482517
6.

Heregulins implicated in cellular functions other than receptor activation.

Breuleux M, Schoumacher F, Rehn D, Küng W, Mueller H, Eppenberger U.

Mol Cancer Res. 2006 Jan;4(1):27-37.

7.

Granulosa cell tumors express erbB4 and are sensitive to the cytotoxic action of heregulin-beta2/PE40.

Furger C, Fiddes RJ, Quinn DI, Bova RJ, Daly RJ, Sutherland RL.

Cancer Res. 1998 May 1;58(9):1773-8.

9.

Formation of a high affinity heregulin binding site using the soluble extracellular domains of ErbB2 with ErbB3 or ErbB4.

Fitzpatrick VD, Pisacane PI, Vandlen RL, Sliwkowski MX.

FEBS Lett. 1998 Jul 10;431(1):102-6.

10.

Blockage of heregulin expression inhibits tumorigenicity and metastasis of breast cancer.

Tsai MS, Shamon-Taylor LA, Mehmi I, Tang CK, Lupu R.

Oncogene. 2003 Feb 6;22(5):761-8.

PMID:
12569369
11.

Isoliquiritigenin (ISL) inhibits ErbB3 signaling in prostate cancer cells.

Jung JI, Chung E, Seon MR, Shin HK, Kim EJ, Lim SS, Chung WY, Park KK, Park JH.

Biofactors. 2006;28(3-4):159-68.

PMID:
17473376
12.

Heregulin-alpha and heregulin-beta expression is linked to a COX-2-PGE2 pathway in human gastric fibroblasts.

Nagata K, Wada K, Tatsuguchi A, Futagami S, Gudis K, Miyake K, Tsukui T, Sakamoto C.

Am J Physiol Gastrointest Liver Physiol. 2006 Jun;290(6):G1243-51. Epub 2005 Dec 15.

PMID:
16357062
13.

Expression of heregulins and associations with the ErbB family of tyrosine kinase receptors in papillary thyroid carcinomas.

Fluge O, Akslen LA, Haugen DR, Varhaug JE, Lillehaug JR.

Int J Cancer. 2000 Sep 15;87(6):763-70.

14.

Segregation of receptor and ligand regulates activation of epithelial growth factor receptor.

Vermeer PD, Einwalter LA, Moninger TO, Rokhlina T, Kern JA, Zabner J, Welsh MJ.

Nature. 2003 Mar 20;422(6929):322-6.

PMID:
12646923
16.
17.

Inhibition of heregulin signaling by an aptamer that preferentially binds to the oligomeric form of human epidermal growth factor receptor-3.

Chen CH, Chernis GA, Hoang VQ, Landgraf R.

Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9226-31. Epub 2003 Jul 21.

18.

Activation of Stat3 by heregulin/ErbB-2 through the co-option of progesterone receptor signaling drives breast cancer growth.

Proietti CJ, Rosemblit C, Beguelin W, Rivas MA, Díaz Flaqué MC, Charreau EH, Schillaci R, Elizalde PV.

Mol Cell Biol. 2009 Mar;29(5):1249-65. doi: 10.1128/MCB.00853-08. Epub 2008 Dec 22.

19.

A high-affinity ErbB4Fc fusion protein is a potent antagonist of heregulin-mediated receptor activation.

Koziolek EJ, Donoghue JF, Bentley JD, Lovrecz G, Dolezal O, Ward CW, Rothacker J, Nice EC, Burgess AW, Hafner M, Johns TG, Adams TE.

Growth Factors. 2012 Oct;30(5):310-9. Epub 2012 Aug 2.

PMID:
22856597
20.

Dynamically varying interactions between heregulin and ErbB proteins detected by single-molecule analysis in living cells.

Hiroshima M, Saeki Y, Okada-Hatakeyama M, Sako Y.

Proc Natl Acad Sci U S A. 2012 Aug 28;109(35):13984-9. doi: 10.1073/pnas.1200464109. Epub 2012 Aug 13.

Supplemental Content

Support Center